Bondholders approve amendment to bond terms and conditions

15-12-2022   Regulatory press release

ADDvise Group AB (publ) (the "Company") today announces the successful completion of the written procedure that was initiated on 21 November 2022 (the "Written Procedure") in relation to the Company's outstanding senior secured bonds with ISIN SE0015222088 (the "Bonds"), seeking approval from bondholders for certain amendments to the terms and conditions of the Bonds (the "Proposal").

A sufficient number of bondholders participated in the written procedure in order to form a quorum, and a requisite majority of bondholders voted in favour of the Proposal.

Each Bondholder is eligible to receive a consent fee in an amount equal to 0.50 per cent of the nominal amount of each Bond held by the relevant bondholder on the Consent Fee Record Date (as defined in the Written Procedure) which will be 22 December 2022. Settlement of the consent fee is expected to occur on 30 December 2022.

The conditions for payment of the consent fee are specified in detail in the formal and detailed notice of the Written Procedure and are available on the Company's website, www.addvisegroup.com.

Pareto Securities AB acted as financial advisor in connection with the written procedure.

For additional information, please contact:

Rikard Akhtarzand, CEO
+46 765-25 90 71
rikard.akhtarzand@addvisegroup.se

Hanna Myhrman, General Counsel
+46 709-82 92 23
hanna.myhrman@addvisegroup.se

Important information:

This information is by ADDvise Group AB required to disclose under the EU Market Abuse Regulation. The information was submitted for publication on December 15, 2022, at 17:30 CET. 
 

About ADDvise Group

ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The group consists of two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expand the business – both geographically and product wise. ADDvise Group’s shares are listed on Nasdaq First North Premier Growth Market and Mangold Fondkommission AB is the Company's Certified Adviser. Additional information is available at www.addvisegroup.com.